Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Biochim Biophys Acta ; 1770(6): 890-901, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17363172

RESUMEN

GPR26 and GPR78 are orphan GPCRs (oGPCRs) that share 51% amino acid sequence identity and are widely expressed in selected tissues of the human brain as well as the developing and adult mouse brain. Investigation of the functional activity of GPR26 and GPR78 via expression in HEK293 cells showed that both proteins are constitutively active and coupled to elevated cAMP production. Accordingly, in yeast, GPR26 demonstrated apparent agonist-independent coupling to a chimeric Gpa1 protein in which the 5 C-terminal amino acids were from Galphas. A comparison of the proteins revealed an atypical glutamine residue in GPR78 in place of the conserved arginine residue (R3.50) in the so-called DRY box. Site-directed mutants R3.50 in GPR26 were constructed and retained their constitutive activity suggesting that these 2 receptors activate G proteins in a manner that is distinct from other group 1 GPCRs.


Asunto(s)
Encéfalo/metabolismo , Receptores Acoplados a Proteínas G/biosíntesis , Animales , Secuencia de Bases , Encéfalo/citología , Línea Celular , AMP Cíclico/biosíntesis , Chaperón BiP del Retículo Endoplásmico , Subunidades alfa de la Proteína de Unión al GTP/biosíntesis , Subunidades alfa de la Proteína de Unión al GTP/genética , Subunidades alfa de la Proteína de Unión al GTP Gq-G11 , Humanos , Masculino , Ratones , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Mutación Missense , Receptores Acoplados a Proteínas G/genética , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/genética , Proteínas de Saccharomyces cerevisiae/biosíntesis , Proteínas de Saccharomyces cerevisiae/genética , Homología de Secuencia de Aminoácido
2.
J Pharmacol Toxicol Methods ; 55(3): 303-13, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-16990017

RESUMEN

INTRODUCTION: Nitric oxide (NO) has been implicated in a wide range of physiological and pathological processes. Low concentrations of this mediator play homeostatic roles, whereas many acute and chronic responses are associated with excessive production of NO. This upregulation is due in part to the induction of inducible nitric oxide synthase (iNOS) by proinflammatory cytokines in several different cell types, including macrophages and their CNS derivative, microglia. METHODS: The crystal structures of the oxygenase domains of mouse and human iNOS were superimposed using the "align by homology" feature in Sybyl (SYBYL 7.0, Tripos Inc.). NOS isoform expression was assessed by TaqMan, Western blotting, and activity assays. RESULTS: We demonstrate that there is a high degree of three-dimensional overlap between the mouse and human iNOS active centers and propose that the murine isoform can serve as a suitable substitute for the human in assays. We also demonstrate that LPS stimulation of the mouse macrophage cell line RAW 264.7 induces the expression of iNOS, but not nNOS or eNOS, at the levels of mRNA transcription and protein expression. Furthermore, the pharmacology and calcium dependency of the NO formation support the finding that it is due to iNOS alone. Also reported is the demonstration of LPS-induced RAW 264.7 macrophages in simple cell-based and cell-free screening assays for iNOS inhibitors. Both assays were reproducible, as demonstrated by Z' factors of 0.69 and 0.71, and had high signal to noise ratios of 11- and 6-fold for the cell-based and cell-free assay, respectively. DISCUSSION: Our computational analyses indicate that there is a high degree of three-dimensional overlap between the oxygenase domains of human and murine iNOS. This observation together with the selective induction of murine iNOS in RAW 264.7 macrophages demonstrates the potential utility of the mouse iNOS assay to identify inhibitors of the human enzyme.


Asunto(s)
Regulación de la Expresión Génica , Lipopolisacáridos/farmacología , Óxido Nítrico Sintasa de Tipo II/metabolismo , Óxido Nítrico/metabolismo , Homología Estructural de Proteína , Animales , Western Blotting , Calcio , Línea Celular , Simulación por Computador , Citocinas , Humanos , Macrófagos/metabolismo , Ratones , Microglía/metabolismo , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Isoformas de Proteínas , ARN Mensajero , Reproducibilidad de los Resultados , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Alineación de Secuencia , Especificidad de la Especie , Transcripción Genética
3.
Bioinformatics ; 20(18): 3490-9, 2004 Dec 12.
Artículo en Inglés | MEDLINE | ID: mdl-15297294

RESUMEN

MOTIVATION: Determining the coupling specificity of G-protein coupled receptors (GPCRs) is important for understanding the biology of this class of pharmacologically important proteins. Currently available in silico methods for predicting GPCR-G-protein coupling specificity have high error rate. METHOD: We introduce a new approach for creating hidden Markov models (HMMs) based on a first guess about the importance of various residues. We call these knowledge restricted HMMs to emphasize the fact that the state space of the HMM is restricted by the application of a priori knowledge. Specifically, we use only those amino acid residues of GPCRs which are likely to interact with G-proteins, namely those that are predicted to be in the intra-cellular loops. Furthermore, we concatenate these predicted loops into one sequence rather than considering them as four disparate units. This reduces the HMM state space by drastically decreasing the sequence length. RESULTS: Our knowledge restricted HMM based method to predict GPCR-G-protein coupling specificity has an error rate of <1%, when applied to a test set of GPCRs with known G-protein coupling specificity. AVAILABILITY: Academic users can get the data set mentioned herein and HMMs from the authors.


Asunto(s)
Proteínas de Unión al GTP/química , Modelos Químicos , Mapeo de Interacción de Proteínas/métodos , Receptores Acoplados a Proteínas G/química , Alineación de Secuencia/métodos , Análisis de Secuencia de Proteína/métodos , Sitios de Unión , Simulación por Computador , Cadenas de Markov , Modelos Estadísticos , Unión Proteica , Homología de Secuencia de Aminoácido , Relación Estructura-Actividad
4.
J Virol ; 78(6): 2921-34, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14990710

RESUMEN

The purified T-antigen origin binding domain binds site specifically to site II, the central region of the simian virus 40 core origin. However, in the context of full-length T antigen, the origin binding domain interacts poorly with DNA molecules containing just site II. Here we investigate the contributions of additional core origin regions, termed the flanking sequences, to origin recognition and the assembly of T-antigen hexamers and double hexamers. Results from these studies indicate that in addition to site-specific binding of the T-antigen origin binding domain to site II, T-antigen assembly requires non-sequence-specific interactions between a basic finger in the helicase domain and particular flanking sequences. Related studies demonstrate that the assembly of individual hexamers is coupled to the distortions in the proximal flanking sequence. In addition, the point in the double-hexamer assembly process that is regulated by phosphorylation of threonine 124, the sole posttranslational modification required for initiation of DNA replication, was further analyzed. Finally, T-antigen structural information is used to model various stages of T-antigen assembly on the core origin and the regulation of this process.


Asunto(s)
Antígenos Virales de Tumores/metabolismo , Modelos Moleculares , Origen de Réplica/fisiología , Virus 40 de los Simios/metabolismo , Ensamble de Virus , Animales , Antígenos Virales de Tumores/química , Secuencia de Bases , Células Cultivadas , Replicación del ADN , Datos de Secuencia Molecular , Spodoptera , Replicación Viral
5.
Arch Biochem Biophys ; 420(1): 55-67, 2003 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-14622975

RESUMEN

The NARC 1 gene encodes a novel proteinase K family proteinase. The domain structure of rat Narc 1 resembles that of the subtilisin-like proprotein convertases (SPCs), except that rNarc 1 lacks the canonical P-domain of SPCs, retaining only the RGD motif as part of what might be a cryptically functioning P-domain. Narc 1 undergoes autocatalytic intramolecular processing at the site LVFAQ/, resulting in the cleavage of its prosegment and the generation of an active proteinase with a broad alkaline pH optimum and no apparent calcium requirement for activity. Both primary and secondary structural determinants influence Narc 1 substrate recognition. Our functional characterization of Narc 1 reinforces the inference drawn from the analysis of its predicted structure that this enzyme is most closely related to representatives of the proteinase K family, but that it is also sufficiently different to warrant its possible classification in a separate sub-family.


Asunto(s)
Endopeptidasa K/química , Endopeptidasa K/metabolismo , Modelos Químicos , Alineación de Secuencia , Análisis de Secuencia de Proteína , Serina Endopeptidasas/química , Serina Endopeptidasas/metabolismo , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Calcio/química , Activación Enzimática , Estabilidad de Enzimas , Regulación Enzimológica de la Expresión Génica/fisiología , Concentración de Iones de Hidrógeno , Datos de Secuencia Molecular , Oligopéptidos/química , Proproteína Convertasa 9 , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Ratas , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Homología de Secuencia , Relación Estructura-Actividad , Temperatura
6.
FEBS Lett ; 524(1-3): 163-71, 2002 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-12135761

RESUMEN

The p53 tumor suppressor protein induces cell cycle arrest or apoptosis in response to cellular stresses. We have identified PRG3 (p53-responsive gene 3), which is induced specifically under p53-dependent apoptotic conditions in human colon cancer cells, and encodes a novel polypeptide of 373 amino acids with a predicted molecular mass of 40.5 kDa. PRG3 has significant homology to bacterial oxidoreductases and the apoptosis-inducing factor, AIF, and the gene was assigned to chromosome 10q21.3-q22.1. Expression of PRG3 was induced by the activation of endogenous p53 and it contains a p53-responsive element. Unlike AIF, PRG3 localizes in the cytoplasm and its ectopic expression induces apoptosis. An amino-terminal deletion mutant of PRG3 that lacks a putative oxidoreductase activity retains its apoptotic activity, suggesting that the oxidoreductase activity is dispensable for the apoptotic function of PRG3. The PRG3 gene is thus a novel p53 target gene in a p53-dependent apoptosis pathway.


Asunto(s)
Flavoproteínas/genética , Regulación de la Expresión Génica/fisiología , Proteínas de la Membrana/genética , Proteínas Mitocondriales , Proteínas/genética , Proteína p53 Supresora de Tumor/fisiología , Adenosina Difosfato/metabolismo , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Factor Inductor de la Apoptosis , Proteínas Reguladoras de la Apoptosis , Secuencia de Bases , Sitios de Unión , Mapeo Cromosómico , Cromosomas Humanos Par 10 , Clonación Molecular , ADN , Genes Reporteros , Humanos , Hibridación Fluorescente in Situ , Datos de Secuencia Molecular , Proteínas/química , ARN Mensajero/genética , Homología de Secuencia de Aminoácido , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...